Transcatheter Mitral Cerclage Ventriculoplasty: 5-Year Outcomes
7 affiliations
- 1Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
- 2MedStar Washington Hospital Center and Georgetown University, Washington, DC, USA.
- 3Structural Heart and Valve Center, Emory University Hospital, Atlanta, GA, USA.
- 4Carilion Clinic, Roanoke, VA, USA.
- 5St Francis Hospital, Roslyn, NY, USA.
- 6WellSpan Health York Hospital, York, PA, USA.
- 7Office of Biostatistics Research, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract
BACKGROUND: Transcatheter mitral cerclage ventriculoplasty places a circumferential tensioning loop around the base of the left ventricle to reduce mitral annular dimensions and reshape ventricular geometry in patients with functional mitral regurgitation and heart failure. Early experience demonstrated reductions in mitral regurgitation and improvements in heart failure symptoms. METHODS: The National Heart, Lung, and Blood Institute Division of Intramural Research Transcatheter Mitral Cerclage Ventriculoplasty Early Feasibility Study was an investigator-initiated, prospective, multicenter study. Between 1 and 5 years, vital status, serious adverse events, routine clinical documentation, and site-reported transthoracic echocardiography findings were collected. RESULTS: Nineteen procedures were attempted in 18 participants (63% heart failure with reduced ejection fraction, 37% heart failure with preserved ejection fraction). Median age was 73 years, and 63% were female. Kaplan-Meier estimated 5-year survival was 57%. One participant underwent left ventricular assist device implantation after 2 years, and 1 participant underwent mitral transcatheter edge-to-edge repair after 3 years; none underwent heart transplantation. The study was suspended after complete heart block developed in 6 participants, including 4 requiring new cardiac implantable electronic devices. Among participants with available follow-up echocardiography, site-reported imaging demonstrated mitral regurgitation reduction and improved left ventricular ejection fraction through 5 years. Symptomatic improvement was most apparent during the first year and attenuated thereafter. CONCLUSIONS: Cerclage ventriculoplasty was associated with mitral regurgitation reduction and improved ventricular function among participants with available long-term follow-up. Symptomatic benefit was greatest during the first year and diminished thereafter, suggesting that favorable remodeling may not fully offset progression of the underlying cardiomyopathy. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03929913.
Related
- Outcomes of Surgical Versus Transcatheter Mitral Valve Repair or Replacement in Patients With Myocardial Infarction and Concomitant Mitral Regurgitation: A Retrospective Analysis of Real-World Data
- Impact of Tricuspid Regurgitation on Outcomes After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation: The PRIME-MR Registry
- Association between iatrogenic atrial septal shunt VTI and clinical outcomes after mitral transcatheter edge-to-edge repair
- Outcomes of rescue procedures in patients undergoing unsuccessful deployment of transcatheter mitral valve replacement.
- Initial Clip Selection and Outcomes After Mitral Transcatheter Edge-to-Edge Repair: A Single-Center Experience
BibTeX
@article{rogers2026transcatheter,
title = {{Transcatheter Mitral Cerclage Ventriculoplasty: 5-Year Outcomes}},
author = {Toby Rogers and Adam B. Greenbaum and Vasilis C. Babaliaros and Jason R. Foerst and Jaffar M. Khan and Christopher G. Bruce and Annette M. Stine and Xin Tian and Robert J. Lederman},
journal = {Circulation. Cardiovascular interventions},
year = {2026},
month = nov,
doi = {10.1161/circinterventions.126.017202},
url = {https://doi.org/10.1161/circinterventions.126.017202},
note = {CC BY},
}
RIS
TY - JOUR
TI - Transcatheter Mitral Cerclage Ventriculoplasty: 5-Year Outcomes
AU - Toby Rogers
AU - Adam B. Greenbaum
AU - Vasilis C. Babaliaros
AU - Jason R. Foerst
AU - Jaffar M. Khan
AU - Christopher G. Bruce
AU - Annette M. Stine
AU - Xin Tian
AU - Robert J. Lederman
PY - 2026
DA - 2026/11/11
JO - Circulation. Cardiovascular interventions
DO - 10.1161/circinterventions.126.017202
UR - https://doi.org/10.1161/circinterventions.126.017202
AB - BACKGROUND: Transcatheter mitral cerclage ventriculoplasty places a circumferential tensioning loop around the base of the left ventricle to reduce mitral annular dimensions and reshape ventricular geometry in patients with functional mitral regurgitation and heart failure. Early experience demonstrated reductions in mitral regurgitation and improvements in heart failure symptoms. METHODS: The National Heart, Lung, and Blood Institute Division of Intramural Research Transcatheter Mitral Cerclage Ventriculoplasty Early Feasibility Study was an investigator-initiated, prospective, multicenter study. Between 1 and 5 years, vital status, serious adverse events, routine clinical documentation, and site-reported transthoracic echocardiography findings were collected. RESULTS: Nineteen procedures were attempted in 18 participants (63% heart failure with reduced ejection fraction, 37% heart failure with preserved ejection fraction). Median age was 73 years, and 63% were female. Kaplan-Meier estimated 5-year survival was 57%. One participant underwent left ventricular assist device implantation after 2 years, and 1 participant underwent mitral transcatheter edge-to-edge repair after 3 years; none underwent heart transplantation. The study was suspended after complete heart block developed in 6 participants, including 4 requiring new cardiac implantable electronic devices. Among participants with available follow-up echocardiography, site-reported imaging demonstrated mitral regurgitation reduction and improved left ventricular ejection fraction through 5 years. Symptomatic improvement was most apparent during the first year and attenuated thereafter. CONCLUSIONS: Cerclage ventriculoplasty was associated with mitral regurgitation reduction and improved ventricular function among participants with available long-term follow-up. Symptomatic benefit was greatest during the first year and diminished thereafter, suggesting that favorable remodeling may not fully offset progression of the underlying cardiomyopathy. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03929913.
SN - 1941-7640
SN - 1941-7632
ER -